Kidney Failure, Chronic: all 2,121 studies

Page 4 of 22. Open to participants first (264), then studies with results posted, then the rest; newest registration first within each.

• Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular HemodialysisCompletedNCT04523220Phase 2Results posted
• Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis ParticipantsCompletedNCT04484857Phase 3Results posted
• Ellipsys Vascular Access System Post Market Surveillance (PS) StudyCompletedNCT04484220Not applicableResults posted
• Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)CompletedNCT04473430Not applicableResults posted
• Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis ParticipantsCompletedNCT04410198Phase 3Results posted
• A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal FunctionActive, not recruitingNCT04398745Phase 1Results posted
• Shared Decision Making in DialysisCompletedNCT04392440Not applicableResults posted
• Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)CompletedNCT04283994Not applicableResults posted
• Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)CompletedNCT04281784Not applicableResults posted
• An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis SystemCompletedNCT04198012Not applicableResults posted
• Advancing Understanding of Transportation OptionsCompletedNCT04141891Not applicableResults posted
• Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for DialysisCompletedNCT04135417Phase 2Results posted
• SPIRIT for Persons With Dementia and Complex MultimorbidityCompletedNCT04108000Not applicableResults posted
• Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).CompletedNCT04094064Not applicableResults posted
• Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRDCompletedNCT04087213Not applicableResults posted
• A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis PatientsCompletedNCT04042324Phase 1/2Results posted
• A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HPCompletedNCT03988920Phase 4Results posted
• Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic HemodialysisCompletedNCT03963895Phase 2Results posted
• HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing HemodialysisCompletedNCT03934736Phase 1Results posted
• Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney FunctionCompletedNCT03874117Not applicableResults posted
• Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)CompletedNCT03873038Phase 1Results posted
• Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD)TerminatedNCT03812679Not applicableResults posted
• Multi-center Study to Transplant Hepatitis-C Infected KidneysCompletedNCT03781726Phase 4Results posted
• Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease PatientsCompletedNCT03781089Phase 4Results posted
• A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney DiseaseCompletedNCT03740048Phase 3Results posted
• Facilitating Communication StudyCompletedNCT03721952Not applicableResults posted
• Effect of Vitamin D Supplementation on Balance in CKDTerminatedNCT03710161Phase 4Results posted
• Predictors of Response to Iron and Erythropoietin Stimulating AgentsCompletedNCT03658876Phase 4Results posted
• Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney FailureTerminatedNCT03645681Not applicableResults posted
• Deprescribing for Older Dialysis PatientsCompletedNCT03631290Results posted
• Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive DonorsCompletedNCT03627299Phase 4Results posted
• Interventions Made to Preserve Cognitive FunctionTerminatedNCT03616535Not applicableResults posted
• Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic HemodialysisCompletedNCT03612856Phase 2Results posted
• Cook Enforcer Post-Market StudyCompletedNCT03552289Not applicableResults posted
• Graft-first Versus Fistula-first in Older Patients With End-stage Kidney DiseaseCompletedNCT03545113Not applicableResults posted
• Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease PatientsTerminatedNCT03539861Not applicableResults posted
• Clinical Study to Assess the Performance of the Dialyzer With Endexo™CompletedNCT03536663Not applicableResults posted
• Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing HemodialysisCompletedNCT03534284Phase 3Results posted
• Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study ACompletedNCT03519347Not applicableResults posted
• A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney FunctionCompletedNCT03482024Phase 1Results posted
• Sodium Chloride and Contrast NephropathyCompletedNCT03476460Phase 2Results posted
• Blood Pressure Lowering in Dialysis (BOLD) TrialCompletedNCT03459807Phase 2Results posted
• The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut MicrobiomeCompletedNCT03452189Phase 2Results posted
• Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis PatientsCompletedNCT03408639Phase 3Results posted
• A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on HemodialysisCompletedNCT03358030Phase 2Results posted
• The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With HyperkalemiaCompletedNCT03326583Phase 2Results posted
• Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD PatientsCompletedNCT03303144Phase 1/2Results posted
• Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance HemodialysisCompletedNCT03301740Not applicableResults posted
• Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis AccessTerminatedNCT03300024Not applicableResults posted
• Extended Release Tacrolimus vs. Twice-Daily TacrolimusCompletedNCT03289650Phase 3Results posted
• Omega 3 Fatty Acids in Patients With Chronic Renal DiseaseCompletedNCT03280615Phase 3Results posted
• Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) PatientsCompletedNCT03257410Not applicableResults posted
• VasQ External Support for Arteriovenous FistulaCompletedNCT03242343Not applicableResults posted
• Ixazomib for DesensitizationCompletedNCT03213158Phase 2Results posted
• Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant RecipientsCompletedNCT03194321Phase 4Results posted
• Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)CompletedNCT03171545Not applicableResults posted
• Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney)CompletedNCT03149328Not applicableResults posted
• Anti-Cytokine Therapy for Hemodialysis InflammatIONCompletedNCT03141983Phase 2Results posted
• An Effectiveness-Implementation Trial of SPIRIT in ESRDCompletedNCT03138564Not applicableResults posted
• Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement TherapyTerminatedNCT03078504Not applicableResults posted
• Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal DiseaseCompletedNCT03036852Phase 2Results posted
• Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal DiseaseCompletedNCT03036839Phase 2Results posted
• Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)CompletedNCT02966028Phase 2Results posted
• Data Collection for Next Generation Ultrasound Technology DevelopmentCompletedNCT02946229Not applicableResults posted
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial FibrillationCompletedNCT02942407Phase 4Results posted
• Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)CompletedNCT02933450Phase 4Results posted
• Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial)CompletedNCT02933151Not applicableResults posted
• Pilot Study of Nutrition in Maintenance Hemodialysis PatientsCompletedNCT02917278Not applicableResults posted
• Disparities in National Kidney Allocation PolicyCompletedNCT02879812Not applicableResults posted
• Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis CentersCompletedNCT02823600Not applicableResults posted
• OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFOCompletedNCT02819011Phase 2Results posted
• HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)CompletedNCT02806505Phase 3Results posted
• A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch TestCompletedNCT02790437Phase 2Results posted
• Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative RecipientsCompletedNCT02781649Phase 4Results posted
• Transplanting Hepatitis C Kidneys Into Negative Kidney RecipientsCompletedNCT02743897Phase 1/2Results posted
• Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD PatientsCompletedNCT02739100Phase 1Results posted
• VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDCCompletedNCT02685995Not applicableResults posted
• An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)CompletedNCT02675998Phase 3Results posted
• A Study of Ferric Citrate to Improve Inflammation and Lipid LevelsTerminatedNCT02661295Phase 4Results posted
• Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream InfectionCompletedNCT02651428Phase 3Results posted
• Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisCompletedNCT02644941Phase 3Results posted
• Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult VolunteersCompletedNCT02636049Phase 1Results posted
• Advance Care Planning With Older Patients Who Have End-stage Kidney DiseaseCompletedNCT02631200Not applicableResults posted
• Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15HCompletedNCT02627118Not applicableResults posted
• Use of Pedometers to Measure and Increase Walking Among Patients With ESRDCompletedNCT02623348Not applicableResults posted
• A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)CompletedNCT02617784Phase 1Results posted
• Product Evaluation for the Effectiveness of the ClearGuard™ HD End CapCompletedNCT02604264Not applicableResults posted
• Triferic Pediatric Pharmacokinetic ProtocolCompletedNCT02595437Phase 1/2Results posted
• Product Evaluation for the Effectiveness of the ClearGuard® HD End CapCompletedNCT02593149Not applicableResults posted
• Gut Microbiome and p-Inulin in HemodialysisCompletedNCT02572882Not applicableResults posted
• Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]CompletedNCT02532621Not applicableResults posted
• Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula OutcomesCompletedNCT02513303Phase 3Results posted
• A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal DiseaseCompletedNCT02512068Phase 3Results posted
• Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease PatientsCompletedNCT02506868Phase 3Results posted
• Helping Olfaction and Nutrition On Renal ReplacementCompletedNCT02479451Phase 2Results posted
• TARGTEPO Treatment for Anemia in PD US TrialTerminatedNCT02468414Phase 2Results posted
• The EvAluation of TaBlo In-CLinic and In-HOmeCompletedNCT02460263Not applicableResults posted
• Renal Osteodystrophy: An Individual Management ApproachCompletedNCT02440581Not applicableResults posted
• A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis PatientsCompletedNCT02433210Not applicableResults posted
• Does Intravenous Iron Therapy Decrease Serum Phosphorous Levels?CompletedNCT02420119Results posted

← Kidney Failure, Chronic overview